AzTrials
AzTrials

Post Induction HypotensionNCT07618416

Machine Learning Model Based on Baroreflex Sensitivity for Predicting Post-Induction Hypotension in Elderly Patients

An observational study of Post Induction Hypotension, run by Peking Union Medical College Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to develop a high-performance machine learning model combining dynamic baroreflex sensitivity (BRS) metrics and multi-dimensional static clinical features to predict the risk of post-induction hypotension (PIH) in elderly patients undergoing elective non-cardiac surgery under general… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Post Induction Hypotension
How many people
500 participants
Where
1 siteChina
Study dates
1 Jun 2026to 31 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients scheduled for elective operations

Who may be able to join

  • Aged over 65 years;
  • Scheduled for elective non-cardiac surgery;
  • American Society of Anesthesiologists (ASA) physical status classification I-III;
  • Planned for general anesthesia with endotracheal intubation;
  • Patient and legal guardians are capable of understanding the study protocol and willing to provide written informed consent.

Who cannot join

  • Severe peripheral vascular diseases;
  • Secondary hypertension;
  • Presence of physical tremors (e.g., Parkinson's disease) preventing stable recording;
  • Inability to accurately measure upper limb blood pressure;
  • Pre-existing cardiac arrhythmias (e.g., atrial fibrillation) that render BRS;
  • Psychiatric disorders or cognitive impairments hindering basic cooperation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Quexuan Cui, Dr. contact

+8613520921711

Cuiqx_garfield@126.com

China1 site, 1 recruiting
  • Peking Union Medical College Hospital

    Beijing, China, 100730

    Quexuan Cui, 13520921711, Cuiqx_garfield@126.com

    Recruiting

Other trials in China

About this study

Official title: Development of a Baroreflex Sensitivity-Based Multifactorial Machine Learning Model for Predicting Post-Induction Hypotension in Elderly Patients

The purpose of this study is to develop a high-performance machine learning model combining dynamic baroreflex sensitivity (BRS) metrics and multi-dimensional static clinical features to predict the risk of post-induction hypotension (PIH) in elderly patients undergoing elective non-cardiac surgery under general anesthesia.

Read the detailed description

Aging significantly alters cardiovascular autonomic function, characterized by elevated sympathetic and decreased parasympathetic tone, rendering elderly patients highly vulnerable to post-induction hypotension (PIH). While existing machine learning models heavily rely on static data (e.g., baseline blood pressure, demographics, medication history), they lack real-time dynamic regulatory inputs, limiting their predictive performance in individualized care.

This single-center, prospective cohort study aims to bridge this gap by introducing preoperative BRS parameters-calculated via the continuous non-invasive arterial pressure (CNAP) method-into machine learning frameworks. A total of 500 patients aged over 65 years scheduled for elective non-cardiac surgery will be enrolled. Preoperative data, including autonomic indices, frailty assessments, and static clinical factors, will be mapped alongside intraoperative events and 30-day postoperative complications. Multiple machine learning algorithms (Logistic Regression, Random Forest, GBDT, XGBoost, LightGBM, and LSTM) will be leveraged and optimized using cross-validation to construct a robust clinical decision-support pipeline.

Keywords
post-induction hypotension, elderly patient, baroreflex sensitivity, machine learning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07618416
Study groupRoleWhat they receive
Elderly Surgical PatientsPatients aged over 65 years who are undergoing elective non-cardiac surgery under general anesthesia with endotracheal intubation. All patients will receive continuous non-invasive hemodynamic monitoring prior to anesthesia induction to calculate baseline BRS parameters.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Post-Induction Hypotension (PIH)

    Defined as a systolic blood pressure (SBP) <90 mmHg , a mean arterial pressure (MAP) <65 mmHg, or a decrease in MAP exceeding 30% from baseline measurements.

    Measured: From immediately after anesthesia induction up to 20 minutes post-induction or before surgical incision.

Secondary outcomes (2)
  1. 1. Early Intraoperative Hypotension Rate

    Defined as a systolic blood pressure (SBP) <90 mmHg , a mean arterial pressure (MAP) <65 mmHg, or a decrease in MAP exceeding 30% from baseline measurements.

    Measured: From surgical incision to the end of the operation.

  2. Postoperative Complication

    Measured: Up to 30 days post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2026
  2. Study start1 Jun 2026 (estimated)
  3. Primary completion30 Sep 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07618416
Sponsor's protocol ID
2025-PUMCH-A-119
Other IDs
2025-PUMCH-A-119
Status last verified
May 2026
First submitted
25 May 2026
Last updated
1 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Post Induction Hypotension, run by Peking Union Medical College Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Quexuan Cui, Dr. (+8613520921711, Cuiqx_garfield@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Post-Induction Hypotension (PIH) (time frame: From immediately after anesthesia induction up to 20 minutes post-induction or before surgical incision.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in